Brent J Klinkhammer, MD | |
100 Woods Rd, Valhalla, NY 10595-1530 | |
(914) 493-7000 | |
Not Available |
Full Name | Brent J Klinkhammer |
---|---|
Gender | Male |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 100 Woods Rd, Valhalla, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1144740184 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | PT16474 (North Dakota) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | 8059 (Nebraska) | Primary |
Mailing Address | Practice Location Address |
---|---|
Brent J Klinkhammer, MD 100 Woods Rd, Valhalla, NY 10595-1530 Ph: () - | Brent J Klinkhammer, MD 100 Woods Rd, Valhalla, NY 10595-1530 Ph: (914) 493-7000 |
News Archive
Patients with normal left ventricular function who undergo elective unprotected left main coronary artery (ULMCA) percutaneous coronary intervention (PCI) with drug-eluting stents (DES) had favorable outcomes according to new research. Results of the multicenter, retrospective study are reported in the June issue of Catheterization and Cardiovascular Interventions, a journal published by Wiley-Blackwell on behalf of The Society for Cardiovascular Angiography and Interventions (SCAI).
A new aggregate data set that provides information on healthcare activity and outcomes of shielded patients has been published by NHS Digital today.
The Electronic Healthcare Network Accreditation Commission, a non-profit standards development organization and accrediting body, today announced the second stage of public review and comment for its Health Information Exchange Accreditation Program. Compared to the first phase of the program's public review in February, which focused on privacy and security, technical performance, business practices and organizational resources, this second phase will explicitly address HIE-specific policies as developed by the HIE Advisory Board.
The U.S. Patent Office has awarded Dr. George Radziszewski a U.S. Patent (No. 7,342,664) for his revolutionary ChemiD Mini Lab, a miniature device that will identify chemical compounds on demand.
› Verified 6 days ago